Volume : 09, Issue : 10, October – 2022
Title:
21.REVIEW OF IMPORTANCE OF NURSING COMMUNICATION IN CRITICAL CARE PATIENT’S FAMILIES
Authors :
Sultan Alharbi, Mansour Al manea, Saleh Alzahrani, Malak Almatrafi, Abeer Alharbi, Hana Hawsawi, Yousef Alsaedi, Ibrahim Al-harbi , Abdulelah Alamri, Aish Aljahdali
Abstract :
Nurses’ perceptions of their role when communicating with families in intensive care units a very important main management approaches in critical area. Narrative review of qualitative and quantitative empirical studies of the impact of nursing communication on critical patient’s family, through data sources used were PubMed, for all papers that were published up to the end of 2021. Communication between nurse, patient, and family member’s entails more than just information exchange. It includes addressing a variety of issues, enabling the expression of feelings and worries regarding the illness, treatment, and prognosis, and assisting patients and family members in regaining control and searching for meaning and purpose in their lives. Strong communication skills in nurses have been demonstrated to positively influence cancer patients’ happiness, overall well-being, and patient experiences.
Cite This Article:
Please cite this article in Sultan Alharbi et al, Review Of Importance Of Nursing Communication In Critical Care Patient’s Families., Indo Am. J. P. Sci, 2022; 09(10).
Number of Downloads : 10
References:
1. Davidson JE, Powers K, Hedayat KM, et al. Clinical practice guidelines for support of the family in the patient-centered intensive care unit: American College of Critical Care Medicine Task Force 2004-2005. Crit Care Med. 2007 Feb;35(2):605–622.
2. Nelson JE, Puntillo KA, Pronovost PJ, et al. In their own words: patients and families define high-quality palliative care in the intensive care unit. Crit Care Med. 2010 Mar;38(3):808–818.
3. Mularski RA, Curtis JR, Billings JA, et al. Crit Care Med. Vol. 34. United States: 2006. Proposed quality measures for palliative care in the critically ill: a consensus from the Robert Wood Johnson Foundation Critical Care Workgroup; pp. S404–411.
4. Liaschenko J, O’Conner-Von S, Peden-McAlpine C. The “big picture”: communicating with families about end-of-life care in intensive care unit. Dimens Crit Care Nurs. 2009 Sep-Oct;28(5):224–231.
5. Scheunemann LP, McDevitt M, Carson SS, Hanson LC. Chest. Vol. 139. United States: 2011. Randomized, controlled trials of interventions to improve communication in intensive care: a systematic review; pp. 543–554.
6. Azoulay E, Pochard F, Chevret S, et al. Impact of a Family Information Leaflet on Effectiveness of Information Provided to Family Members of Intensive Care Unit Patients. American Journal of Respiratory and Critical Care Medicine. 2002;165:438–442.
7. Azoulay E, Pochard F, Chevret S, et al. Meeting the needs of intensive care unit patient families: a multicenter study. American Journal of Respiratory and Critical Care Medicine. 2001;163(1):135–139.
8. Azoulay E, Sprung cL. Family-Physician Interactions in the Intensive Care Unit. Critical Care Medicine. 2004;32(11):2323–2328.
9. Heyland D, Cook D, Rocker G, et al. Decision-making in the ICU: perspectives of the substitute decision-maker. Intensive Care Medicine. 2003;29(1):75–82.
10. Lautrette A, Darmon M, Megarbane B, et al. A communication strategy and brochure for relatives of patients dying in the ICU. New England Journal of Medicine. 2007;356(5):469–478.
11. Lehmann LL, Brancati FL, Chen M-C, Roter D, Dobs AS. The effect of bedside case presentations on patients’ perceptions of their medical care. New England Journal of Medicine. 1997;336(16):1150–1155.
12. Wang-Cheng R, Barnsas G, Sigmann P, Riendl P, Young M. Bedside case presentations: why patients like them but learner’s don’t. Journal of General Internal Medicine. 1989;4(4):284–287.
13. Azoulay E, Pochard F, Chevret S, et al. Half the family members of intensive care unit patients do not want to share in the decision-making process: a study in 78 French intensive care units. Critical Care Medicine. 2004;32(9):1832–1838.
14. LeClaire M, Oakes J, Weinert C. Communication of prognostic information for critically ill patients. Chest. 2005;128(3):1728–1735.
15. Gerstel E, Engelberg RA, Koepsell T, Curtis JR. Duration of Withdrawal of Life Support in the Intesive Care Unit and Association with Family Satisfaction. American Journal of Respiratory and Critical Care Medicine. 2008;178:798–804.
16. Curtis JR. Caring for patients with critical illness and their families: the value of an integrated team. Respiratory Care. 2008;53(4):480–7.
17. Beckstrand RL, Kirchhoff KT. Providing end-of-life care to patients: critical care nurses’ perceived obstacles and supportive behaviors. American Journal of Critical Care. 2005;14(5):395–403.
18. Curtis JR, Treecy PD, Nielsen EL, et al. Integrating palliative and critical care: evaluation of a quality-improvement intervention. American Journal of Respiratory and Critical Care Medicine. 2008;178:269–275.
19. Hamric AB, Blackhall LJ. Nurse-physician perspectives on the care of dying patients in intensive care units: Collaboration, moral distress, and ethical climate. Critical Care Medicine. 2007;35(2):422–429.
20. Ho KM. The involvement of intensive care nurses in end-of-life decisions: a nationwide survey. Intensive Care Medicine. 2005;31:668–673.
21. Davidson JE, Powers K, Hedayat KM, et al. Clinical practice guidelines for support of the family in the patient-centered intensive care unit: American College of Crticial Care Medicine taskforce. Critical Care Medicine. 2007;35(2):605–622.
22. Treece PD, Engelberg RA, Shannon SE, et al. Integrating palliative and critical care: description of an intervention. Critical Care Medicine. 2008;34(11 Suppl):2380–7.
23. Ferrand E, Lemaire F, Regnier B, et al. Am J Respir Crit Care Med. Vol. 167. United States: 2003. Discrepancies between perceptions by physicians and nursing staff of intensive care unit end-of-life decisions; pp. 1310–1315.
24. Thomas EJ, Sexton JB, Helmreich RL. Discrepant attitudes about teamwork among critical care nurses and physicians. Crit Care Med. 2003 Mar;31(3):956–959.
25. Yaguchi A, Truog RD, Curtis JR, et al. Arch Intern Med. Vol. 165. United States: 2005. International differences in end-of-life attitudes in the intensive care unit: results of a survey; pp. 1970–1975.
26. Vazirani S, Hays RD, Shapiro MF, Cowan M. Am J Crit Care. Vol. 14. United States: 2005. Effect of a multidisciplinary intervention on communication and collaboration among physicians and nurses; pp. 71–77.
27. O’Leary KJ, Wayne DB, Landler MP, et al. Impact of localizing physicians to hospital units on nurse-physician communication and agreement on the plan of care. J Gen Intern Med. 2009 Nov;24(11):1223–1227.
28. Curtis JR, White DB. Chest. Vol. 134. United States: 2008. Practical guidance for evidence-based ICU family conferences; pp. 835–843.
29. Jacobowski NL, Girard TD, Mulder JA, Ely EW. Communication in Critical Care: Family Rounds in the Intensive Care Unit. American Journal of Critical Care. 2010 Sep 1;19(5):421–430. 2010.
30. Curtis JR, Nielsen EL, Treece PD, et al. Effect of a Quality-Improvement Intervention on End-of-Life Care in the Intensive Care Unit: A Randomized Trial. Am. J. Respir. Crit. Care Med. 2010 Sep 10;:201006–201004OC. 2010.
Volume : 09, Issue : 10, October – 2022
Title:
16.FORMULATION AND EVALUATION OF CONTROLLED RELEASE OF ASPIRIN TABLET USING DIRECT COMPRESSION METHOD
Authors :
Neha Fathima*, Dr. Jyothi P, Dr. R. Hemalatha
Abstract :
The coordinate compression approach, which has been around for a long time, benefits quickly dissolving definitions significantly. Furthermore, various concentrations of the super disintegrant were used to provide the most bioavailable information possible. In definitions with a predominant super disintegrant, in vitro crumbling time and disintegration will be accelerated, while friability and weight change will be reduced. When super disintegrants are used to create a fast-dissolving tablet, it is faster and releases the pharmaceutical sooner than a conventionally developed tablet. A cumulative rate of Headache medicine tablets with varying concentrations of CCS and Maize Starch were discovered to have been freed from the definition over time.
In this study, F7’s solvency clearly outperforms F1, F2, F3, F4, F5, and F6. Aspirin quick dissolving tablets can be successfully manufactured, and it is anticipated that the availability of a wide range of mechanical alternatives and a few advantages will lead to an increase in quiet compliance and its notoriety in the near future.
Keywords: super disintegrant, solvency, dissolving tablets
Cite This Article:
Please cite this article in Neha Fathima et al Formulation And Evaluation Of Controlled Release Of Aspirin Tablet Using Direct Compression Method, Indo Am. J. P. Sci, 2022; 09(10).
Number of Downloads : 10
References:
1. Sastry.S.V., Nyshadham.J.R. and Fix.J.A. Recent technological advances in oral Drug delivery – a review. Pharm Sci Technol Today, 3, 2000; pp. 138–145.
2. Rathbone.M.J., Hadgraft.J. and Roberts.M.S. Modified release drug delivery technology. Marcel Dekker, 2003; New York.
3. Lordi.N.G. Sustained release dosage forms. In: Lachman, L., Lieberman, The theory and practice of industrial pharmacy, 3rd edn. Varghese Publishing House, Bombay, 1987; pp.430– 456.
4. Chiao.C.S.L. and Robinson.J.R. Sustained release drug delivery systems. Remington: the science and practice of pharmacy, vol. II. Mack Publishing Company, Easton, PA, pp. 1995; 1660–1675.
5. Kydonieus.A.F. Fundamental concepts of controlled release. In: Controlled release technologies: Methods, theory, and applications. vol. I. CRC, Florida, 1990; pp. 1–19.
6. Lordi N.G. “Sustained release dosage form” chapter 14 in “Theory and practice of Industrial Pharmacy” , 3rd edition, Varghese Publishing House, 1991;p. 430-431.
7. Welling.P.G., Dobrinska.M.R. Chapter 6 in “Controlled drug delivery: Fundamentals and applications”, 2nd edition, Marcel Dekker Inc., Volume 29, 1978: pp.254-289.
8. Madhukat, Mansukalal.D, Milind, Dattatraya Joshi and Bharat Pravinchandra. M. Pharmaceutical composition for controlled drug delivery system, patent No: US 7,157,100 B2, ; 2007.
9. James Swarbrick, James C. Boylan. Encyclopedia of Pharmaceutical Technology.2007; pp. 369-394.
10. Venkataraman Daar.S N, Chester.A, Kliener.L. An overview of Controlled release systems, Handbook of Pharmaceutical Controlled release technology, Marcel dekker Inc: 2000; p p.1-30.
11. Gilberts, Banker, Neil R. Anderson, Sustained release dosage forms; The Theory and Practice of Industrial Pharmacy, 2001; 3rd edition.pp.430- 456.
12. Rudnic E. and Schawartz J.B, Oral solid dosage forms, Remington’s Pharmaceutical Sciences, Mack Publishing Company, Easton, Pennsylvania,1965; pp. 2000.
13. Ahmad, A. B., Bennett, P. N. & Rowland, M. Influence of route of hepatic administration on drug availability. Journal of Pharmacology and Experimental Therapeutics 230, 1984; pp.718—725.
14. Joseph Robinson. R, Vincent H. L. Lee, Controlled drug delivery fundamentals and applications, Marcel Dekker Inc, New York:3- 61.2002.
15. Birkett.D.J. Half-life, Pharmacokinetics made easy, Australian prescriber, 11: 1996; p.57-59.
16. Hogan, J.E. Hydroxypropylmethylcellulose sustained release technology. Drug Dev Ind Pharm, 1989; pp. 975–999.
17. Velasco.M.V., Ford. J.L., Rowe.P. and Rajabi-Siahboomi, A.R. Influence of drug: HPMC ratio, drug and Polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. J Control Release, 1999; 57, pp. 75–85.
18. Mitchell. K., Ford, J.L., Armstrong, D.J., Elliott, P.N., Hogan, J.E. and Rostron, C. The influence of drugs on the properties of gels and swelling characteristics of matrices Containing methylcellulose or hydroxypropylmethylcellulose. Int J Pharm, 1993; pp.165–17.
19. Ford.J.L., Rubinstein.M.H., Changela.A. and Hogan.J.E. The influence of pH on the dissolution of promethazine hydrochloride from hpmc controlled release tablets. J Pharm. Pharmacol, 1985; 37, pp.115-119.
20. Levina.M., Gothoskar.A. and Rajabi Siahboomi.A. Application of a Modeling system in the formulation of extended-release hydrophilic matrices. Pharm Technol Eur, 2006; 18, pp.20–26.